Cavernous Dysfunction: Viagra And Other Oral Medications: Revision history

From GTMS

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 December 2025

17 December 2025

  • curprev 17:1917:19, 17 December 2025 CharmainLamble talk contribs 3,991 bytes +3,991 Created page with "<br><br><br>Cavernous dysfunction is a park stipulation that affects an estimated 30 to 50 million hoi polloi in the Concerted States. The AUC of the alive metabolite, N-desmethyl sildenafil, was increased 62% by closed circuit and potassiumsparing diuretics and 102% by nonspecific beta-blockers. These personal effects on the metabolite are not expected to be of clinical import. Tagamet (800 mg), a nonspecific CYP inhibitor, caused a 56% increment in plasm Viagra concen..."
Retrieved from "http://mefsvs03.ad.gatech.edu/index.php?title=Cavernous_Dysfunction:_Viagra_And_Other_Oral_Medications"